Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Cheng

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 19, 2019
Long-term Liver-related Outcomes of Patients With Chronic Liver Diseases in AustraliaYi Huang, John Joseph, W Bastiaan de Boer, et al.
Plos One|March 4, 2014
A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisonersLorraine Yap, Susan Carruthers, Sandra Thompson, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 15, 2020
Hepascore predicts liver outcomes and all-cause mortality in long-term methotrexate users: A retrospective cohort studyZhengyi Wang, Yi Huang, Hans Nossent, et al.
BMC Infectious Diseases|October 30, 2020
A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis CJessica Ramsay, Julie Marsh, Alisa Pedrana, et al.
Journal of Gastroenterology and Hepatology|December 16, 2011
Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: a multicenter clinical experienceDilip Ratnam, Anouk Dev, Tin Nguyen, et al.
Journal of Gastroenterology and Hepatology|December 5, 2008
Interferon-induced thyroid dysfunction in chronic hepatitis CKhaleel M Jamil, Peter J Leedman, Nickolas Kontorinis, et al.
Bioorganic & Medicinal Chemistry|February 10, 2009
Synthesis, SAR study and biological evaluation of novel pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as anti-proliferative agentsYanong D Wang, Erick Honores, Biqi Wu, et al.
The American Journal of Gastroenterology|August 22, 2025
The Portal Hypertension Decompensation Score - A Validated Predictive Model of Liver Decompensation Related to Portal HypertensionAngus W Jeffrey, Avik Majumdar, Gary Jeffrey, et al.
The American Journal on Addictions|December 10, 2013
A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patientsWilfrid Noel Raby, Eric A Rubin, Fatima Garawi, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1William Sievert, Gregory J Dore, Geoffrey W McCaughan, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 19, 2019
Long-term Liver-related Outcomes of Patients With Chronic Liver Diseases in AustraliaYi Huang, John Joseph, W Bastiaan de Boer, et al.
Plos One|March 4, 2014
A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisonersLorraine Yap, Susan Carruthers, Sandra Thompson, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 15, 2020
Hepascore predicts liver outcomes and all-cause mortality in long-term methotrexate users: A retrospective cohort studyZhengyi Wang, Yi Huang, Hans Nossent, et al.
BMC Infectious Diseases|October 30, 2020
A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis CJessica Ramsay, Julie Marsh, Alisa Pedrana, et al.
Journal of Gastroenterology and Hepatology|December 16, 2011
Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: a multicenter clinical experienceDilip Ratnam, Anouk Dev, Tin Nguyen, et al.
Journal of Gastroenterology and Hepatology|December 5, 2008
Interferon-induced thyroid dysfunction in chronic hepatitis CKhaleel M Jamil, Peter J Leedman, Nickolas Kontorinis, et al.
Bioorganic & Medicinal Chemistry|February 10, 2009
Synthesis, SAR study and biological evaluation of novel pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as anti-proliferative agentsYanong D Wang, Erick Honores, Biqi Wu, et al.
The American Journal of Gastroenterology|August 22, 2025
The Portal Hypertension Decompensation Score - A Validated Predictive Model of Liver Decompensation Related to Portal HypertensionAngus W Jeffrey, Avik Majumdar, Gary Jeffrey, et al.
The American Journal on Addictions|December 10, 2013
A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patientsWilfrid Noel Raby, Eric A Rubin, Fatima Garawi, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1William Sievert, Gregory J Dore, Geoffrey W McCaughan, et al.
Pageof 7